SABS (SAB Biotherapeutics) Forvard P/E multiplikatori
SAB Biotherapeutics (SABS) hozirda 1-tur diabetga qarshi kurashishning innovatsion usulini klinik tasdiqlash bosqichidan o'tmoqda. Kompaniyaning oldingi P/E koeffitsiyenti tendentsiyasi bozor kutganlarini aniq namoyish etmoqda, bunda 0.00 darajasi parametrning holatini ko'rsatadi. Biznes transgenik chorva mollari poliklonal antitanachlaridan foydalangan holda himoya to'sig'ini yaratmoqda. DiversitAb platformasi saraton va viruslarga qarshi oqsillarning tezkor ishlab chiqarilishini ta'minlab, strategik xavfsizlikni kafolatlaydi.
SAB Biotherapeutics kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- biznesning bozor baholash ko'rsatkichlari:
- balans kapitallashuvi haqida ma'lumot:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati SAB Biotherapeutics|SABS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics|SABS - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar SAB Biotherapeutics Inc.|SABS - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi SAB Biotherapeutics|Tezkor likvidlik koeffitsiyenti sabbiotherapeutics.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
SABS - Sof foyda|Prognoz qilingan kelajakdagi foyda SAB Biotherapeutics|SABS - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati SAB Biotherapeutics, Inc|SABS - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|EV/EBITDA multiplikatori SAB Biotherapeutics Inc.|SABS - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) SAB Biotherapeutics|SABS - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi sabbiotherapeutics.com|SABS - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi SAB Biotherapeutics
Kompaniyaning jamlanma tahliliyoti:SAB Biotherapeutics, Inc.
Antitela platformasi uchun yuqori ishlab chiqish xarajatlari va SAB Biotherapeutics (SABS) kompaniyasining tashqi kapitalga bog'liqligi foyda prognozlarini baholashning muhim omiliga aylantiradi. Kompaniyaning kutilayotgan P/E bahosini tahlil qilish orqali investor kelajakdagi sof daromadning bir dollari qiymatini aniqlaydi, bu esa aktivlarning haddan tashqari qiziganini yoki uzoq muddatli kapital barqarorligiga bevosita ta'sir qiluvchi yashirin xatarlarni aniqlash imkonini beradi.
SAB Biotherapeutics (SABS) raqobatchilari
Prognoz qilingan narxning foydaga nisbati ARGX (argenx)|BNTX (BioNTech Inc.) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (abivax.com)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati ADMA Corp (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|immunovant.com (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols SA|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori Celldex Corp|Kelajakdagi narxning foydaga nisbati Aurinia Pharmaceuticals (AUPH)|biocryst.com - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Prognoz qilingan narx-foyda nisbati|PHVS - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati AbCellera Biologics ABCL|TRML: Forvard P/E multiplikatori|precigen.com (PGEN) - Forvard P/E multiplikatori|PHAR (Pharming Group) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati NKTR|Prognoz qilingan narxning foydaga nisbati UPB (Upstream Bio Corp)|ZBIO (Zenas Corp) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori IMNM (Immunome, Inc.)|gossamerbio.com - Kelajakdagi narxning foydaga nisbati|KalVista Pharmaceuticals, Inc. - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Septerna, Inc. SEPN|Pieris Pharmaceuticals Inc (PVLA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Savara Pharma (SVRA)|Prognoz qilingan narxning foydaga nisbati RIGL|ANAB (anaptysbio.com) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori ATXS|ENGN (enGene Holdings Inc) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori RAPT (RAPT Therapeutics, Inc.)|Aerovate Therapeutics, Inc. (JBIO) - Prognoz qilingan narx-foyda nisbati|ACRS - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori KYTX (kyvernatx.com)|TLSA: Forvard P/E multiplikatori|Cabaletta Bio Inc. (CABA) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Ventyx Bio|Theratechnologies, Inc - Narxning kutilayotgan foydaga nisbati|Forvard P/E multiplikatori AVTX|ELDN - Prognoz qilingan narx-foyda nisbati|Agenus Inc. - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Climb Bio Inc. CLYM|ZURA: Prognoz qilingan narxning foydaga nisbati|aTyr Pharmaceuticals - Kapitalizatsiyaning kelajakdagi foydaga nisbati|ADAG: Forvard P/E multiplikatori|IMA - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|STTK (Shattuck Labs Inc) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Equillium Bio (EQ)|Kelajakdagi narxning foydaga nisbati Connect Biopharma (CNTB)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati immunic-therapeutics.com|Kelajakdagi narxning foydaga nisbati Atara Bio ATRA|Kapitalizatsiyaning prognoz qilingan foydaga nisbati InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. - Forvard P/E multiplikatori|ACET - Forvard P/E multiplikatori|CELU: Forvard P/E multiplikatori|INMB (INmune Bio Corporation) - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Barinthus Biotherapeutics|kezarlifesciences.com (KZR) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Akari Therapeutics Plc (AKTX)|ENLV: Narxning kutilayotgan foydaga nisbati|Forvard P/E multiplikatori QTTB (Q32 Bio)|Kelajakdagi narx-foyda multiplikatori GOVX|Edesa Biotech, Inc. - Forvard P/E multiplikatori|IBIO - Forvard P/E multiplikatori|carismatx.com (CARM) - Kelajakdagi narxning foydaga nisbati|XTL Biopharmaceuticals Ltd - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Bolt Biotherapeutics Inc.|Prognoz qilingan narxning foydaga nisbati HCW Biologics Inc (HCWB)|Forvard P/E multiplikatori APVO|Forvard P/E multiplikatori AIM ImmunoTech, Inc. (AIM)|Aditxt, Inc. - Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori GRI|XORTX - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Vyome Therapeutics HIND|Revelation Biosciences (REVB) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati indaptusrx.com|Kelajakdagi narxning foydaga nisbati Scinai Immunotherapeutics Ltd.|Prognoz qilingan narxning foydaga nisbati CalciMedica Corp (CALI)|Prognoz qilingan narxning foydaga nisbati AFMD (Affimed)|Forvard P/E multiplikatori allakos.com (ALLK)|Kelajakdagi narxning foydaga nisbati HOOKIPA Pharma HOOK|IGMS: Narxning kelajakdagi foydaga nisbati|iTeos Therapeutics, Inc. - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Ocean Biomedical Inc|TC BioPharm (Holdings) PLC (TCBP) - Kelajakdagi narxning foydaga nisbati|THRD - Kapitalizatsiyaning prognoz qilingan foydaga nisbati
